Orthopedic Biomaterials Market Analysis

  • Report ID: 3547
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Orthopedic Biomaterials Market Segmentation:

Material Segment Analysis

The global orthopedic biomaterials market is segmented and analyzed for demand and supply by material into ceramics & bioactive glasses, polymers, metals, and calcium phosphate cements. Out of the four segments, the  polymer segment is set to hold more than 34% orthopedic biomaterials market share by 2035. The major factor for segment growth is the rising use of polymers as bone cement and load-bearing surfaces for total joint arthroplasties. In addition, the easy availability of cost-effective polymers and biopolymers that are advantageous for various uses in ortho biologics and bio-resorbable tissue fixation is expected to surge the demands of polymer-based orthopedic biomaterial globally and impetus segment growth. Furthermore, the advantages offered by polymers such as high flexibility, enhanced strength, and increased durability are also expected to expand their application use and help in expanding the segment size.

Application Segment Analysis

The global orthopedic biomaterials market is also segmented and analyzed for demand and supply by application into joint reconstruction, bio-resorbable tissue fixation, ortho biologics, viscosupplementation, orthopedic implants, and others. Amongst these segments, orthopedic implants segment is poised to hold substantial orthopedic implants market share by 2035. The major factor for segment growth is the rising number of keyhole orthopedic surgery across the world coupled with the increased prevalence of bone fractures. For instance, it has been calculated that in the United States, almost 2 million fractures occur every year. Furthermore, the rising number of bone diseases such as osteoporosis, osteopenia, osteoarthritis, osteomyelitis, and rapid escalation of musculoskeletal conditions is anticipated to fuel revenue generation and drive segment growth during the forecast period.

Our in-depth analysis of the global market includes the following segments:

          By Material

  • Ceramics & Bioactive Glasses
  • Polymers
  • Metals
  • Calcium Phosphate Cement

        By Application

  • Joint Reconstruction
  • Bio-Resorbable Tissue Fixation
  • Orthobiologics
  • Viscosupplementation
  • Orthopedic Implants
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of orthopedic biomaterials is estimated at USD 25.84 billion.

The global orthopedic biomaterials market size was more than USD 24.19 billion in 2025 and is anticipated to grow at a CAGR of over 7.6%, reaching USD 50.32 billion revenue by 2035.

The North America orthopedic biomaterials market is forecasted to secure a 31% share by 2035, driven by a large pool of patients with musculoskeletal diseases, rising R&D investments, and higher disposable incomes increasing adoption of advanced orthopedic biomaterials.

Key players in the market include Evonik Industries AG, Stryker Corporation, DePuy Synthes Inc., Zimmer Biomet Holdings Inc., Invibio Ltd., Koninklijke DSM N.V., Victrex Plc., Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos